Here are six drug companies that made headlines in the past week.
1. Tacoma, Wash., files suit against 3 drugmakers for alleged role in opioid epidemic
Attorneys for the city of Tacoma, Wash., filed a lawsuit against Purdue Pharma, Endo Health Solutions and Janssen Pharmaceuticals for allegedly providing physicians and patients with misleading information regarding the safety and efficacy of their respective opioid products.
2. Teva to sell contraceptive device business for $1.1B, divest remaining women's health assets
Israel-based Teva Pharmaceuticals will sell Paragard, its hormone-free intrauterine device, to Pleasanton, Calif.-based Cooper Companies for $1.1 billion.
3. Drugmaker Alexion restructures, cuts 20% of its workforce
Alexion Pharmaceuticals plans to lay off 20 percent of its global workforce as part of its corporate strategy advancement plan.
4. Lundbeck CEO leaves post to lead Teva: 5 things to know
Teva Pharmaceuticals named Lundbeck's Kare Schultz its new CEO.
More articles on supply chain:
Teva to sell contraceptive device business for $1.1B, divest remaining women's health assets
6 must-reads for supply chain leaders
Supply chain inefficiencies leave $23B in potential savings on the table for hospitals